These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21981375)

  • 21. Docosanol: new drug. Herpes labialis: barely more effective than an excipient.
    Prescrire Int; 2009 Jun; 18(101):106-7. PubMed ID: 19637417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
    Fife KH; Warren TJ; Justus SE; Heitman CK;
    Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized double-blind trial of tromantadine versus aciclovir in recurrent herpes orofacialis.
    Ostheimer KE; Busch T; Görtelmeyer R; Hahn KD
    Arzneimittelforschung; 1989 Sep; 39(9):1152-5. PubMed ID: 2686658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical honey application vs. acyclovir for the treatment of recurrent herpes simplex lesions.
    Al-Waili NS
    Med Sci Monit; 2004 Aug; 10(8):MT94-8. PubMed ID: 15278008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kanuka honey versus aciclovir for the topical treatment of herpes simplex labialis: a randomised controlled trial.
    Semprini A; Singer J; Braithwaite I; Shortt N; Thayabaran D; McConnell M; Weatherall M; Beasley R
    BMJ Open; 2019 May; 9(5):e026201. PubMed ID: 31092654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of acyclovir gel in herpes simplex: clinical implications.
    Seth AK; Misra A; Umrigar D; Vora N
    Med Sci Monit; 2003 Jul; 9(7):PI93-8. PubMed ID: 12883465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can clinical trials requiring frequent participant contact be conducted over the Internet? Results from an online randomized controlled trial evaluating a topical ointment for herpes labialis.
    Formica M; Kabbara K; Clark R; McAlindon T
    J Med Internet Res; 2004 Feb; 6(1):e6. PubMed ID: 15111272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized clinical study comparing Compeed cold sore patch to acyclovir cream 5% in the treatment of herpes simplex labialis.
    Karlsmark T; Goodman JJ; Drouault Y; Lufrano L; Pledger GW;
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(10):1184-92. PubMed ID: 18462303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection.
    Wald A; Carrell D; Remington M; Kexel E; Zeh J; Corey L
    Clin Infect Dis; 2002 Apr; 34(7):944-8. PubMed ID: 11880960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Penciclovir cream for the treatment of sunlight-induced herpes simplex labialis: a randomized, double-blind, placebo-controlled trial. Penciclovir Cream Herpes Labialis Study Group.
    Boon R; Goodman JJ; Martinez J; Marks GL; Gamble M; Welch C
    Clin Ther; 2000 Jan; 22(1):76-90. PubMed ID: 10688392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.
    Tyring SK; Baker D; Snowden W
    J Infect Dis; 2002 Oct; 186 Suppl 1():S40-6. PubMed ID: 12353186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protocol for a randomised controlled trial of 90% kanuka honey versus 5% aciclovir for the treatment of herpes simplex labialis in the community setting.
    Semprini A; Singer J; Shortt N; Braithwaite I; Beasley R;
    BMJ Open; 2017 Aug; 7(8):e017766. PubMed ID: 28775197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative multi-centre study of the efficacy of propolis, acyclovir and placebo in the treatment of genital herpes (HSV).
    Vynograd N; Vynograd I; Sosnowski Z
    Phytomedicine; 2000 Mar; 7(1):1-6. PubMed ID: 10782483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of the dorsal cutaneous guinea pig model in selecting topical antiviral formulations for the treatment of recurrent herpes simplex type 1 disease.
    Poli G; Dall'Ara P; Binda S; Santus G; Poli A; Cocilovo A; Ponti W
    Arzneimittelforschung; 2001; 51(5):433-8. PubMed ID: 11413746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and tolerability assessment of a topical formulation containing copper sulfate and hypericum perforatum on patients with herpes skin lesions: a comparative, randomized controlled trial.
    Clewell A; Barnes M; Endres JR; Ahmed M; Ghambeer DK
    J Drugs Dermatol; 2012 Feb; 11(2):209-15. PubMed ID: 22270204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials.
    Sarisky RT; Bacon TH; Boon RJ; Duffy KE; Esser KM; Leary J; Locke LA; Nguyen TT; Quail MR; Saltzman R
    Arch Virol; 2003 Sep; 148(9):1757-69. PubMed ID: 14505088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No significant analgesic benefit of adding lidocaine 2% to aciclovir 5% cream as treatment of episodes of herpes labialis.
    Bodsworth NJ; Bayerl C; Cunningham A; Silny W
    Herpes; 2003 Aug; 10(2):53-4. PubMed ID: 14577955
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy and safety of foscarnet for recurrent orolabial herpes: a multicentre randomized double-blind study.
    Lawee D; Rosenthal D; Aoki FY; Portnoy J
    CMAJ; 1988 Feb; 138(4):329-33. PubMed ID: 2962712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life.
    Handsfield HH; Warren T; Werner M; Phillips JA
    Sex Transm Dis; 2007 Jun; 34(6):339-43. PubMed ID: 17065847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, double-blind, placebo-controlled study to test the efficacy of topical 2-hydroxypropyl-Beta-cyclodextrin in the prophylaxis of recurrent herpes labialis.
    Senti G; Iannaccone R; Graf N; Felder M; Tay F; Kündig T
    Dermatology; 2013; 226(3):247-52. PubMed ID: 23816977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.